Showing results (51-60 of 290) with videos related to
Sort By:
Pageof 29
Lung Cancer (Amsterdam, Netherlands)|October 1, 2018
Carving out another slice of the pie: Exceptional response to single agent imatinib in an asian female never-smoker with advanced NSCLC with a de-novo PDGFR-α N848 K mutationSamuel J Klempner, Kyle Gowen, Thomas K Lee, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 2, 2009
Clinical definition of acquired resistance to epidermal growth factor receptor tyrosine kinase inhibitors in non-small-cell lung cancerDavid Jackman, William Pao, Gregory J Riely, et al.Clinical Lung Cancer|July 6, 2016
Yield and Clinical Utility of Next-Generation Sequencing in Selected Patients With Lung AdenocarcinomaDavid M DiBardino, Anjali Saqi, Julia A Elvin, et al.Lung Cancer (Amsterdam, Netherlands)|October 26, 2002
A phase II trial of chemotherapy and surgery for non-small cell lung cancer patients with a synchronous solitary metastasisRobert J Downey, Kenneth K Ng, Mark G Kris, et al.The Oncologist|May 17, 2017
A Case of Metastatic Atypical Neuroendocrine Tumor with <i>ALK</i> Translocation and Diffuse Brain MetastasesVictoria E Wang, Lauren Young, Siraj Ali, et al.Case Reports in Clinical Pathology|December 27, 2014
Unique metastases of ALK mutated lung cancer activated to the adnexa of the uterusAllison H West, S Diane Yamada, Heber MacMahon, et al.Cancer Chemotherapy and Pharmacology|August 13, 2009
A phase I trial of SJG-136 (NSC#694501) in advanced solid tumorsYelena Y Janjigian, Wooin Lee, Mark G Kris, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 31, 2004
Using patients as their own controls for cost evaluation of phase I clinical trialsEric J Sherman, David M Rubin, Ennapadam Venkatraman, et al.Head & Neck|December 23, 2016
Significant and durable clinical benefit from trastuzumab in 2 patients with HER2-amplified salivary gland cancer and a review of the literatureLauren M Thorpe, Alexa B Schrock, Rachel L Erlich, et al.Cancer Immunology Research|April 21, 2019
Phenotypic and Genomic Determinants of Immunotherapy Response Associated with SquamousnessAaron M Goodman, Shumei Kato, Ranajoy Chattopadhyay, et al.Pageof 29